TABLE 2.

Distribution of median patient intervals for each cancer type over 1‐year nonpandemic and three biannual COVID periods

Cancer site	Patient interval (days)
	Nonpandemic period			Early period			Mid‐period			Late period
	N	Median	IQR	N	Median	IQR	N	Median	IQR	N	Median	IQR
Pancreatic	130	18	11‐27	50	52	26‐72	58	45	29‐63	88	38	17‐50.5
Colorectal	125	25	16‐36	44	48	21.5‐67.5	57	42	24‐65	82	37	24‐46
Lung	121	23	18‐38	50	60	31‐84	55	52	31‐69	89	46	25‐59
Esophageal	60	20	8.5‐23	20	28	17.5‐44	24	25	15‐38	35	22	9‐31
Gastric	68	24	15‐36.5	22	66	28‐100	26	57	29‐81	37	53	36‐74
Breast	56	22	16.5‐32	18	31	26‐39	20	27	15‐39.5	32	25	16.5‐36
Head/neck	60	21.5	10‐30.5	21	28	18‐38	22	24	17‐40	33	22	13‐26
KUB	58	16	11‐24	18	25	11‐46	23	22	18‐43	30	17	14‐28
Ovarian	59	21	16‐29	22	50	26‐54	21	43	35‐77	32	37	23.5‐47.5
Endometrial	55	15	9‐20	21	22	17‐30	22	18	14‐30	29	17	12‐25
Liver	52	19	8.5‐23.5	20	43	28.5‐54	23	39	29‐48	28	34	22‐48.5

Note: Just to highlight numbers of cancers in each period

Abbreviations: IQR, interquartile range; KUB, kidney, urinary tract and bladder.